This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB03144/identifier/chebi/
n14http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB03144/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB03144/identifier/bindingdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03144/identifier/pubchem-compound/
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03144/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03144/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03144
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n14:DB03144 n15:DB03144
dcterms:title
N-Omega-Hydroxy-L-Arginine
adms:identifier
n6:43088 n7:DB03144 n9:50230418 n10:46506099 n11:HAR n12:123895
n3:IUPAC-Name
n4:271B5327-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B532D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B532C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5329-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B532A-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B532B-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5325-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5323-363D-11E5-9242-09173F13E4C5 n4:271B5326-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5324-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5333-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5334-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B532E-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B532F-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5331-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5330-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5332-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5339-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B533B-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B533C-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5338-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5337-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B533A-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5328-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5335-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5336-363D-11E5-9242-09173F13E4C5